BP665 0.5 mg Pill - yellow capsule/oblong, 14mm
Pill with imprint BP665 0.5 mg is Yellow, Capsule/Oblong and has been identified as Tacrolimus 0.5 mg. It is supplied by Belcher Pharmaceuticals, LLC.
Tacrolimus is used in the treatment of Organ Transplant, Rejection Prophylaxis; Organ Transplant, Rejection Reversal and belongs to the drug class calcineurin inhibitors. Risk cannot be ruled out during pregnancy. Tacrolimus 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BP665 0.5 mg
Tacrolimus
- Imprint
- BP665 0.5 mg
- Strength
- 0.5 mg
- Color
- Yellow
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Calcineurin inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Belcher Pharmaceuticals, LLC
- National Drug Code (NDC)
- 62250-0665
- Inactive Ingredients
-
lactose anhydrous,
hypromellose 2208 (100 mPa.s),
croscarmellose sodium,
magnesium stearate,
gelatin,
titanium dioxide,
ferric oxide yellow,
shellac,
ferric oxide red,
dimethicone,
hydrated silica
Note: Inactive ingredients may vary.
More about tacrolimus
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (47)
- Drug images
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: calcineurin inhibitors
- Breastfeeding
- En español
Patient resources
- Tacrolimus oral and injection drug information
- Tacrolimus (Intravenous) (Advanced Reading)
- Tacrolimus (Oral) (Advanced Reading)
- Tacrolimus Capsules
- Tacrolimus Extended-Release Tablets
Other brands
Prograf, Envarsus XR, Astagraf XL, Hecoria
Professional resources
Other brands
Prograf, Envarsus XR, Astagraf XL
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
